Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery
- Conditions
- AnemiaArthroplastyReplacementHip
- Interventions
- Other: Allowed drop in hemoglobin to 4.5-5.5 mmol/LOther: Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L
- Registration Number
- NCT00906295
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the postoperative ambulation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- 18 years or older
- Patients undergoing replacement of hip arthroplasty
- Be legally competent
- Read and understand Danish
- Present malignant disease
- Known heart disease with functionality equivalent to NYHA II or CCS II or worse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Allowed drop in hemoglobin to 4.5-5.5 mmol/L Allowed drop in hemoglobin to 4.5-5.5 mmol/L Transfusion with red blood cells to level between 4.5-5.5 mmol/L Allowed drop in hemoglobin to 5.6-6.5 mmol/L Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L Transfusion with red blood cells to level between 5.6-6.5 mmol/L
- Primary Outcome Measures
Name Time Method Timed Up and Go-test (TUG)in seconds. 30 days Timed Up and Go-test is performed when the patient is able to undertake the test after surgery. This is judged by a physiotherapist. The test measures how long it takes the patient to rise, walk 3 meters, turn around, walk back and sit down again.
- Secondary Outcome Measures
Name Time Method The postoperative day patients can walk ten meters 30 days Length of stay at hospital 30 days The day the patient is able to perform Timed Up and Go-test 30 days
Trial Locations
- Locations (2)
Bispebjerg Hospital
🇩🇰Copenhagen, Copenhagen NV, Denmark
Copenhagen University Hospital, Rigshospitalet
🇩🇰Copenhagen, Østerbro, Denmark